Nextage Therapeutics (XTAE:NXTG) Short-Term Debt : ₪0.23 Mil (As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

What is Nextage Therapeutics Short-Term Debt?

Nextage Therapeutics's Short-Term Debt for the quarter that ended in Dec. 2023 was ₪0.23 Mil.

Nextage Therapeutics's quarterly Short-Term Debt increased from Dec. 2022 (₪0.21 Mil) to Jun. 2023 (₪0.23 Mil) and increased from Jun. 2023 (₪0.23 Mil) to Dec. 2023 (₪0.23 Mil).

Nextage Therapeutics's annual Short-Term Debt increased from Dec. 2021 (₪0.20 Mil) to Dec. 2022 (₪0.21 Mil) and increased from Dec. 2022 (₪0.21 Mil) to Dec. 2023 (₪0.23 Mil).

Nextage Therapeutics Short-Term Debt Historical Data

The historical data trend for Nextage Therapeutics's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nextage Therapeutics Short-Term Debt Chart

Nextage Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

1.24

0.19

0.20

0.21

0.23

Nextage Therapeutics Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Short-Term Debt	Get a 7-Day Free Trial									0.20	0.11	0.21	0.23	0.23

Nextage Therapeutics Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Nextage Therapeutics Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Nextage Therapeutics's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Nextage Therapeutics (XTAE:NXTG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nextage Therapeutics Ltd (XTAE:NXTG) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bio-Light, Kiryat Atidim 7, Entrance 1, 2rd Floor, Tel Aviv, ISR, 61581

Website

http://www.m-medic.com

Nextage Therapeutics Ltd is a holding company. The company, through its subsidiaries, is engaged in the development of biological marker, a molecule/gene, which when present in the body at abnormal levels indicates development of a disease. It is focused on the development and commercialization of cancer diagnostic products.

Nextage Therapeutics (XTAE:NXTG) Headlines

From GuruFocus

First Trust Global Portfolios Limited Announces Name Changes for Certain Sub-Funds of First Trust Global Funds plc

By Business Wire Business Wire • 01-29-2021